| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |